Royal Bank of Canada closed 6.3% short of its 52-week high of C$180.45, which the company reached on December 6th.

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target hoisted by Royal Bank of Canada from $402.00 to $407.00 in a research note issued to investors on Tuesday,Benzinga reports.

Royal Bank is up 28% in the past year. Are more gains on the way? The post Outlook for Royal Bank of Canada Stock in 2025 ...

The bank also warned that retaliatory tariffs by Canada and other nations against the U.S. if Donald Trump imposes tariffs could cause a period of inflation.

In an interview Wednesday, OSFI superintendent Peter Routledge said that while uncertainty about whether the United States ...

Equities research analysts at National Bank Financial issued their Q4 2024 earnings per share (EPS) estimates for shares of ...

The UK Supreme Court, by a majority, dismisses HMRC's appeal against RBC over a double tax treaty linked to a North Sea oil ...

The Royal Bank of Canada won’t owe the UK corporation taxes toward payments it received on a North Sea oil production, the ...

The clearing arms of Barclays and Royal Bank of Canada (RBC) set record highs for required swaps margin in December 2024, capping off a year of double-digit growth for both.

U.S. refiners including Valero Energy, Phillips 66 and BP recently said tariffs on Canadian oil imports could lead them to reduce output or deal with logistical issues as they try to find replacement ...

So you've done your best to plan an affordable date, but your significant other has other plans-it's a hotel staycation, ...

The Quebec premier said a tax on products made by Alcoa and Rio Tinto could create leverage in negotiations with President ...